Tonlamarsen sodium

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameTonlamarsen sodium
Drug Alias NameTonlamarsen (Ionis Pharmaceuticals)ION-904AGT-2.5-LRx
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionAngiotensinogen inhibitors
TargetsAngiotensinogen
Therapy Area/IndicationsHypertensionCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesKardigan IncIonis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHypertensionCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A